Provided by Tiger Trade Technology Pte. Ltd.

Glaukos

109.60
+4.374.15%
Post-market: 109.600.00000.00%19:01 EDT
Volume:706.19K
Turnover:76.51M
Market Cap:6.37B
PE:-33.40
High:109.67
Open:106.46
Low:105.40
Close:105.23
52wk High:130.23
52wk Low:73.16
Shares:58.08M
Float Shares:55.40M
Volume Ratio:0.85
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2819
EPS(LYR):-3.2819
ROE:-26.38%
ROA:-5.80%
PB:9.70
PE(LYR):-33.40

Loading ...

Glaukos SVP and Chief Financial Officer Alex R. Thurman disposes of common shares; $505,399 total value

Reuters
·
3 hours ago

Stifel Nicolaus Sticks to Its Buy Rating for Glaukos (GKOS)

TIPRANKS
·
Mar 20

Glaukos Chief Development Officer Tomas Navratil disposes of USD 194,970 in common shares

Reuters
·
Mar 20

Glaukos CFO Alex R. Thurman disposes of USD 123,977 of common shares

Reuters
·
Mar 20

Glaukos Launches Epioxa for Keratoconus Treatment

MT Newswires Live
·
Mar 19

Glaukos announces commercial availability of Epioxa HD/Epioxa

TIPRANKS
·
Mar 19

BTIG Sticks to Its Buy Rating for Glaukos (GKOS)

TIPRANKS
·
Mar 09

Glaukos Highlights Interventional Ophthalmology Strategy in Investor Update

TIPRANKS
·
Mar 02

Glaukos Publishes Investor Presentation on Interventional Glaucoma and Keratoconus Therapies

Reuters
·
Mar 02

Glaukos Expands Eye Care Pipeline With New GLK-321 Trial in Demodex Blepharitis

TIPRANKS
·
Feb 28

High-Profile Insider Move Shakes Up Glaukos Investor Watchlists

TIPRANKS
·
Feb 24

Glaukos Director Aimee S Weisner Disposes of Common Shares

Reuters
·
Feb 24

Glaukos FY 2025 cost of sales jumps 139% to USD 224.68 million

Reuters
·
Feb 23

Morgan Stanley Remains a Sell on Glaukos (GKOS)

TIPRANKS
·
Feb 20

Glaukos Corp. Earnings Call Signals High-Growth Phase

TIPRANKS
·
Feb 19

Stock Track | Glaukos Soars 5.10% Intraday on Positive Analyst Ratings and Price Target Increases

Stock Track
·
Feb 18

Glaukos (GKOS): Strong Execution, Expanding iDose Adoption, and De‑Risked Pipeline Support Buy Rating and $131 Target

TIPRANKS
·
Feb 18

Glaukos: Strengthening Growth, Epioxa Momentum, and Justified Premium Valuation Support Buy Rating

TIPRANKS
·
Feb 18

Glaukos Price Target Maintained With a $131.00/Share by BTIG

Dow Jones
·
Feb 18

Glaukos Reports Record Q4 Sales, Reaffirms 2026 Outlook

TIPRANKS
·
Feb 18